Kestra Medical Technologies (NASDAQ:KMTS – Get Free Report) was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a note issued to investors on Saturday. A number of other equities analysts have also weighed in on KMTS. BTIG Research reaffirmed a “buy” rating and set a $32.00 target [...]